fbpx
QQQ
+ 3.49
315.85
+ 1.09%
DIA
+ 3.04
337.19
+ 0.89%
SPY
+ 4.20
405.97
+ 1.02%
TLT
+ 0.97
134.84
+ 0.72%
GLD
+ 1.17
169.99
+ 0.68%

Israel Researchers Launch Clinical Trials To Test CBD As COVID-19 Treatment Supplement

April 25, 2020 10:37 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Israel Researchers Launch Clinical Trials To Test CBD As COVID-19 Treatment Supplement

By The Fresh Toast's Brendan Bures, provided exclusively to Benzinga Cannabis.

Israeli researchers have launched three clinical trials that utilize CBD’s anti-inflammatory properties as potential COVID-19 treatment.

Israeli scientists have launched clinical trials into whether cannabis can play an effective role in stopping or slowing the coronavirus. Though lung health experts have warned smoking marijuana could exacerbate COVID-19 and its spread, Israeli scientists will study cannabidiol (CBD) alongside existing treatment options as a possible solution.

Last week, InnoCan Pharma announced a collaboration with Tel Aviv University to instill CBD medicine through exosomes — or the small cell structures created when stem cells multiply. The unconventional method will utilize the exosomes as “homing missiles,” as they can uniquely target cell organs damaged by COVID-19. Researchers then believe CBD’s anti-inflammatory properties will repair the damaged cells through a synergistic effect.

As COVID-19 attacks the respiratory system, scientists will have patients receive CBD-enriched exosomes through an inhalation device. Previous studies have shown CBD can help regulate the body’s immune system and reduce inflammation throughout the body.

See Also: Federal Agency To Fund Scientific Research On Cannabis' Effects On COVID-19

A second clinical trial will occur over the coming weeks and includes 10 Covid-19 patients currently undergoing treatment in Israel’s Rabin Medical Center. Doctors will combine traditional steroids and CBD, with the belief CBD will enhance the therapeutic potential of the steroids. The trial, conducted by Stero Biotechs in collaboration with Mor Research Application, already has plans to expand treatment to 40 additional patients should it prove successful.

Noticias sobre cannabis e Israel en Español en El Planteo.

Israel's Unique Approach To Driving And Cannabis Use

Photo by PublicDomainPictures via Pixabay

“We estimate that our CBD-based treatment can enhance the current treatment of those patients who are in life-threatening conditions,” Stero Biotechs founder and CEO David Bassa said in a statement. “Hospitalized COVID-19 patients are mostly being treated with steroids and our study is planned to demonstrate the benefit of a combined solution with Steroid treatments. We are hopeful that this study will lead to faster benefit for the growing number of COVID-19 patients in Israel and around the world.”

See Also: Why Cannabis Has Been Deemed An Essential Business Amid COVID-19 Pandemic

A third study, launched by Tel Aviv’s Ichilov Medical Center, will investigate whether CBD’s anti-inflammatory properties could lower respiratory symptoms experienced in moderate COVID-19 patients.

Canadian researchers have also announced intentions to study what role cannabis can play in slowing COVID-19. They also believe marijuana’s anti-inflammatory properties could provide a crucial role in potential treatment.

Photo by jorono via Pixabay


Related Articles

Can Cannabis Help Ease The Mind In The Age Of COVID-19? New Study Shows It Can

THE SEVENTH RESEARCH STUDY PUBLISHED BY THE UNIVERSITY OF NEW MEXICO AND RELEAF APP CONCLUDES THAT INDIVIDUALS REPORT CANNABIS FLOWER EFFECTIVE IN PROVIDING ANXIETY, STRESS, AND AGITATION/IRRITABILITY RELIEF.  read more

Discover the Right Forms of CBD for You

Products infused with Cannabidiol (CBD) span a wide range of categories, and each form of CBD has its purpose and place. But which one is right for you? Does swallowing a capsule or applying a body butter fit into your routine? How about mixing a powder blend with your drink, or using a face oil? read more

Curaleaf International's Adven GmbH Launches Medical Cannabis Products In Germany

Curaleaf International's subsidiary, Adven GmbH, recently introduced its medical cannabis products in Germany, Europe's largest medical cannabis market. read more

China Bans All Synthetic Cannabinoids

This article by Franca Quarneti was originally published on El Planteo, and appears here with permission. The Chinese government has announced that all synthetic cannabinoids will be included in the list of banned drugs. read more